Nullane salus extra ecclesiam
| Autor: | Philippe Gautret, Didier Raoult |
|---|---|
| Přispěvatelé: | Institut Hospitalier Universitaire Méditerranée Infection (IHU Marseille), Vecteurs - Infections tropicales et méditerranéennes (VITROME), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut de Recherche Biomédicale des Armées [Brétigny-sur-Orge] (IRBA), Microbes évolution phylogénie et infections (MEPHI), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche Biomédicale des Armées (IRBA)-Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU) |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
medicine.medical_specialty 2019-20 coronavirus outbreak [SDV]Life Sciences [q-bio] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 030106 microbiology Group comparison Microbiology Article lcsh:Infectious and parasitic diseases law.invention 03 medical and health sciences Clinical trials Randomized controlled trial law medicine lcsh:RC109-216 Intensive care medicine SARS-CoV-2 business.industry Public health Chloroquine derivatives COVID-19 Outbreak In silico comparison 3. Good health Clinical trial 030104 developmental biology Infectious Diseases Infectious disease (medical specialty) business |
| Zdroj: | New Microbes and New Infections New Microbes and New Infections, Vol 37, Iss, Pp 100714-(2020) NEW MICROBES AND NEW INFECTIONS NEW MICROBES AND NEW INFECTIONS, 2020, 37, ⟨10.1016/j.nmni.2020.100714⟩ |
| ISSN: | 2052-2975 |
| Popis: | Randomized clinical trials are not relevant for infectious disease outbreaks due to a new pathogen, for which public health decisions have to be made urgently. An approach based on group comparisons, in silico, may provide valuable results in a reasonably short period of time for a negligible amount of money. (C) 2020 The Authors. Published by Elsevier Ltd. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|